Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$157,047,110
+$36,272,513 QoQ
Shares Held
2,006,479
+7.4% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#13
of 664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Derivatives in HALO
reported options exposure · as of Jun 30, 2026CallValue
$2,207,214
CallShares
28,200
PutValue
$767,046
PutShares
9,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. HALO ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in HALO
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157,047,110 | 2,006,479 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $767,046 | 9,800 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $2,207,214 | 28,200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,350,767 | 20,900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $120,774,597 | 1,868,708 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $633,374 | 9,800 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $111,009,060 | 1,649,466 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $194,378,501 | 2,650,375 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $52,998,184 | 1,018,804 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39,534,250 | 619,562 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $39,749,903 | 831,414 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,550,470 | 306,612 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $25,068,659 | 478,775 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,127,725 | 298,125 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $945,288 | 25,576 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $842,271 | 22,049 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $403,984 | 11,200 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,026,776 | 26,886 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,728,906 | 30,385 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,068,252 | 27,017 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,060,400 | 24,100 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,382,759 | 34,673 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,172,181 | 228,107 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,206,331 | 226,311 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,862,243 | 437,398 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $36,206,221 | 868,463 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $55,275,452 | 1,294,204 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $62,360,152 | 2,372,913 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $56,324,752 | 2,100,886 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $34,245,637 | 1,903,593 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||